MCM
CVS icon

Maple Capital Management’s CVS Health CVS Stock Holding History

Maple Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-43,213
Closed -$2.69M – 140
2018
Q1 		$2.69M Sell
43,213
-48,745
-53% -$3.5M 0.67% 42
2017
Q4 		$6.67M Buy
91,958
+188
+0.2% +$13.7K 1.71% 24
2017
Q3 		$7.46M Buy
91,770
+1,021
+1% +$80.8K 2.01% 19
2017
Q2 		$7.3M Buy
90,749
+3,099
+4% +$245K 2.1% 18
2017
Q1 		$6.88M Buy
87,650
+2,000
+2% +$160K 2.03% 18
2016
Q4 		$6.76M Buy
85,650
+5,284
+7% +$428K 2.12% 14
2016
Q3 		$7.15M Buy
80,366
+2,558
+3% +$241K 2.32% 10
2016
Q2 		$7.45M Buy
77,808
+709
+0.9% +$70.7K 2.72% 8
2016
Q1 		$8M Buy
77,099
+1,477
+2% +$144K 2.95% 6
2015
Q4 		$7.39M Buy
75,622
+2,800
+4% +$274K 2.62% 9
2015
Q3 		$7.03M Buy
72,822
+3,939
+6% +$414K 2.6% 4
2015
Q2 		$7.22M Buy
68,883
+19,549
+40% +$2M 2.47% 7
2015
Q1 		$5.09M Buy
49,334
+3,060
+7% +$310K 1.77% 24
2014
Q4 		$4.46M Buy
46,274
+5,482
+13% +$483K 1.61% 27
2014
Q3 		$3.25M Buy
40,792
+2,524
+7% +$199K 1.23% 36
2014
Q2 		$2.88M Buy
38,268
+16,185
+73% +$1.22M 1.05% 41
2014
Q1 		$1.65M Buy
22,083
+15,608
+241% +$1.1M 0.64% 51
2013
Q4 		$463K Buy
+6,475
New +$416K 0.18% 85

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Maple Capital Management's CVS Position: Q2 2018 in Review

Maple Capital Management sold out of CVS Health (CVS) in Q2 2018, closing a stake of 43,213 shares — an estimated $2.69M sold.

Maple Capital Management first reported a position in CVS in Q4 2013 and held it in 18 quarters. The position peaked at $8M in Q1 2016. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • Maple Capital Management reported no remaining CVS Health position as of Q2 2018 after selling out during the quarter.
  • Maple Capital Management sold 43,213 CVS Health shares in Q2 2018, an estimated $2.69M.
  • Maple Capital Management first reported a position in CVS Health in Q4 2013 and held it in 18 quarters.
  • Maple Capital Management's CVS Health position peaked at $8M in Q1 2016.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Maple Capital Management's 13F filing for Q2 2018, filed 8 Aug 2018.